Bio-engineered Stent Market
This report contains market size and forecasts of Bio-engineered Stent in global, including the f ... Read More
Pemphigus vulgaris is a rare chronic blistering skin disease and the most common form of pemphigus.
This report contains market size and forecasts of Pemphigus Vulgaris Treatment in Global, including the following market information:
Global Pemphigus Vulgaris Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pemphigus Vulgaris Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pemphigus Vulgaris Treatment include Roche, Novartis, GlaxoSmithKline, Mylan, Genentech, Principia Biopharma, Argenx, Alexion and Vifor Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pemphigus Vulgaris Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pemphigus Vulgaris Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pemphigus Vulgaris Treatment Market Segment Percentages, by Type, 2021 (%)
Oral
Injectable
Global Pemphigus Vulgaris Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pemphigus Vulgaris Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Pemphigus Vulgaris Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pemphigus Vulgaris Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pemphigus Vulgaris Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pemphigus Vulgaris Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
GlaxoSmithKline
Mylan
Genentech
Principia Biopharma
Argenx
Alexion
Vifor Pharma
This report contains market size and forecasts of Bio-engineered Stent in global, including the f ... Read More
Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and ... Read More
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an ep ... Read More
This report contains market size and forecasts of DDI (DNS, DHCP, and IPAM) in Global, including ... Read More